Flu Stocks List


Related Industries: Aerospace & Defense Agricultural Inputs Asset Management Auto Parts Banks - Global Banks - Regional - US Biotechnology Building Materials Business Services Chemicals Confectioners Conglomerates Credit Services Diagnostics & Research Diversified Industrials Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Electronic Components Engineering & Construction Farm & Construction Equipment Grocery Stores Health Information Services Home Furnishings & Fixtures Household & Personal Products Industrial Distribution Industrial Electrical Equipment Industrial Metals & Minerals Insurance - Life Internet Content & Information Internet Content & Information Lumber & Wood Production Marketing Services Medical Care Medical Devices Medical Distribution Medical Instruments & Supplies Metal Fabrication Oil & Gas Drilling Oil & Gas Equipment & Services Oil & Gas Integrated Oil & Gas Refining & Marketing Paper & Paper Products Pollution & Treatment Controls Savings & Cooperative Banks Scientific & Technical Instruments Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Retail Tobacco Tools & Accessories Waste Management

Related ETFs - A few ETFs which own one or more of the above listed Flu stocks.

Flu Stocks Recent News

Date Stock Title
Sep 29 MRK Is Merck Stock a Buy?
Sep 27 MRK Merck snaps six straight sessions of losses
Sep 27 ANIP Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?
Sep 27 MRK Merck & Co., Inc. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts
Sep 26 MRK Merck, Bristol-Myers fail to convince FDA AdCom on wider Opdivo, Keytruda use
Sep 26 MRK Is Merck & Co., Inc. (MRK) the Best Cheap Beginner Stock to Invest In?
Sep 26 SRPT The Play On Sarepta Therapeutics
Sep 26 SRPT Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress
Sep 26 EW Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 26 COCP Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts
Sep 26 MRK Evaxion stock jumps on expanded vaccine development pact with MSD
Sep 26 MRK EVAX Process Continues to Garner Interest and Investment
Sep 26 ANIP ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
Sep 26 MRK Merck to Present New Long-Term Data for Tulisokibart (MK-7240), an Investigational Anti-TL1A Monoclonal Antibody, in Inflammatory Bowel Disease at UEG Week 2024
Sep 26 MRK Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts
Sep 25 MRK FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Sep 25 MRK Merck's Experimental Favezelimab/Keytruda Combo Fails In Late-Stage Colorectal Cancer Study
Sep 25 MRK Merck fails in late-stage trial for Keytruda combo in colon cancer
Sep 25 MRK Merck Provides Update on Phase 3 KEYFORM-007 Trial Evaluating Investigational Fixed-Dose Combination of Favezelimab and Pembrolizumab for Patients With Previously Treated PD-L1 Positive Microsatellite Stable Metastatic Colorectal Cancer
Sep 25 MRK Merck’s KEYTRUDA® (pembrolizumab) Receives New Approvals in Japan for Certain Patients With Non-Small Cell Lung Carcinoma (NSCLC) and Radically Unresectable Urothelial Carcinoma